Remote Monitoring of vital signs can make
the pandemic outbreak of COVID-19 more manageable
Within the framework of a first-in-class study in Munich, cosinuss° provides the pioneering biosensor technology to monitor low and medium risk patients of COVID-19, who are in home isolation. The clinical study is initiated and led by Prof. Dr. Med. Georg Schmidt, head of the Biosignal Analysis Working Group, Klinikum rechts der Isar, Technical University of Munich.
With the monitoring system, cosinuss° provides a highly cost-effective, easy to handle and fast to configure extended workbench for healthcare centers. It consists of an in-ear wearable sensor (cosinuss° Two) a data-gateway (cosinuss° LabApp or cosinuss° LabGateway) and a server database (cosinuss° LabServer).
University Hospital in Munich is testing cosinuss° in-ear senosrs for fighting Covid-19.
The in-ear sensor collects key physiological vital parameters from the patient in isolation, and transmits the data to the cosinuss° server, where early warning algorithms calculate a composite score in real-time. Health professionals access all the vital patient information via a simple web interface. The cosinuss° solution supports health professionals in determining the urgency of the respective health situation and the necessity of hospital admission.
Key physiological parameters that are monitored include:
- Core Body Temperature
- Heart Rate
- Blood Oxygen Saturation
- Respiration Rate